'First-in-class' precision cancer drug shows promising results in Phase I trial
https://healthell.blogspot.com/2020/06/first-in-class-precision-cancer-drug.html
'First-in-class' precision cancer drug shows promising results in Phase I trial
A new drug targeting cancer’s ability to repair its DNA has shown promising results in a Phase I trial.
